When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - Adaptimmune's SPEAR T-cells targeting MAGE-A4 an Orphan Drug in U.S.
Adaptimmune Therapeutics plc
The FDA has granted Orphan Drug Designation (ODD) to Adaptimmune Therapeutics' (NASDAQ:ADAP) SPEAR T-cells targeting MAGE-A4 (ADP-A2M4 program) for the treatment of soft tissue sarcomas.
More news on: Adaptimmune Therapeutics plc, Healthcare stocks news,